G&E Herbal Biotechnology Statistics

Total Valuation

TPEX:4911 has a market cap or net worth of TWD 3.06 billion. The enterprise value is 2.65 billion.

Market Cap	3.06B
Enterprise Value	2.65B

Important Dates

The next estimated earnings date is Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:4911 has 59.00 million shares outstanding. The number of shares has increased by 0.06% in one year.

Current Share Class	n/a
Shares Outstanding	59.00M
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	25.14%
Owned by Institutions (%)	n/a
Float	44.17M

Valuation Ratios

The trailing PE ratio is 30.00.

PE Ratio	30.00
Forward PE	n/a
PS Ratio	12.30
PB Ratio	3.67
P/TBV Ratio	4.37
P/FCF Ratio	23.78
P/OCF Ratio	22.74
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.42, with an EV/FCF ratio of 20.62.

EV / Earnings	26.01
EV / Sales	10.66
EV / EBITDA	20.42
EV / EBIT	22.19
EV / FCF	20.62

Financial Position

The company has a current ratio of 3.61, with a Debt / Equity ratio of 0.00.

Current Ratio	3.61
Quick Ratio	3.42
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.01
Interest Coverage	2,918.20

Financial Efficiency

Return on equity (ROE) is 12.78% and return on invested capital (ROIC) is 9.34%.

Return on Equity (ROE)	12.78%
Return on Assets (ROA)	8.12%
Return on Invested Capital (ROIC)	9.34%
Return on Capital Employed (ROCE)	14.34%
Revenue Per Employee	6.39M
Profits Per Employee	2.62M
Employee Count	39
Asset Turnover	0.27
Inventory Turnover	1.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.79% in the last 52 weeks. The beta is -0.66, so TPEX:4911's price volatility has been lower than the market average.

Beta (5Y)	-0.66
52-Week Price Change	-5.79%
50-Day Moving Average	55.18
200-Day Moving Average	55.77
Relative Strength Index (RSI)	48.47
Average Volume (20 Days)	29,328

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4911 had revenue of TWD 249.03 million and earned 102.06 million in profits. Earnings per share was 1.73.

Revenue	249.03M
Gross Profit	205.34M
Operating Income	119.65M
Pretax Income	124.73M
Net Income	102.06M
EBITDA	129.24M
EBIT	119.65M
Earnings Per Share (EPS)	1.73

Full Income Statement

Balance Sheet

The company has 408.87 million in cash and 1.75 million in debt, giving a net cash position of 407.13 million or 6.90 per share.

Cash & Cash Equivalents	408.87M
Total Debt	1.75M
Net Cash	407.13M
Net Cash Per Share	6.90
Equity (Book Value)	833.53M
Book Value Per Share	14.13
Working Capital	326.14M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 134.68 million and capital expenditures -5.92 million, giving a free cash flow of 128.76 million.

Operating Cash Flow	134.68M
Capital Expenditures	-5.92M
Free Cash Flow	128.76M
FCF Per Share	2.18

Full Cash Flow Statement

Margins

Gross margin is 82.46%, with operating and profit margins of 48.04% and 40.98%.

Gross Margin	82.46%
Operating Margin	48.04%
Pretax Margin	50.08%
Profit Margin	40.98%
EBITDA Margin	51.89%
EBIT Margin	48.04%
FCF Margin	51.70%

Dividends & Yields

This stock pays an annual dividend of 0.76, which amounts to a dividend yield of 1.49%.

Dividend Per Share	0.76
Dividend Yield	1.49%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	31.12%
Buyback Yield	-0.06%
Shareholder Yield	1.43%
Earnings Yield	3.33%
FCF Yield	4.20%

Dividend Details

Stock Splits

The last stock split was on August 20, 2024. It was a forward split with a ratio of 1.06.

Last Split Date	Aug 20, 2024
Split Type	Forward
Split Ratio	1.06

Scores

TPEX:4911 has an Altman Z-Score of 16.84.

Altman Z-Score	16.84
Piotroski F-Score	n/a